US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
USOTC
Nirvana Life Sciences Inc (GM) (NIRVF) 銘柄情報

Nirvana Life Sciences Inc (GM) (NIRVF)

0.0763

0.00

(0.00%)

終了 6月21日 5:00AM

Nirvana Life Sciences Inc (GM) (NIRVF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.0763

( - )

買値

0.0763

売値

0.0763

出来高

-

0.00 日の範囲 0.00

0.0763 52 週間の範囲 0.08

時価総額

前日終値

0.0763

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 9,667

発行済株式数

22,923,301

配当利回り

PER

-0.64

1 株当たり利益 (EPS)

-0.02

歳入

-

純利益

-358.63k

Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction. It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada. Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction. It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada.

セクター

-

業界

-

ウェブサイト

nirvanalifescience.com

本社

Vancouver, Canada

設立

-

Nirvana Life Sciences Inc (GM) is listed in the sector of the その他OTC with ticker NIRVF. The last closing price for Nirvana Life Sciences (GM) was US$0.08. Over the last year, Nirvana Life Sciences (GM) shares have traded in a share price range of US$ 0.0763 to US$ 0.08.

Nirvana Life Sciences (GM) currently has 22,923,301 shares in issue. The market capitalisation of Nirvana Life Sciences (GM) is US$1.75 million. Nirvana Life Sciences (GM) has a price to earnings ratio (PE ratio) of -0.64.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0763	0.0763	0.0763	0	0	CS
26	0	0	0.0763	0.0763	0.0763	0	0	CS
52	-0.0037	-4.625	0.08	0.08	0.0763	263	0.0763	CS
156	0.067967	815.636625465	0.008333	0.08	0.008333	244	0.07470702	CS
260	0.067967	815.636625465	0.008333	0.08	0.008333	244	0.07470702	CS

NIRVF - Frequently Asked Questions (FAQ)

What is the current Nirvana Life Sciences Inc (GM) share price?

The current share price of Nirvana Life Sciences Inc (GM) is US$ 0.0763

How many Nirvana Life Sciences Inc (GM) shares are in issue?

Nirvana Life Sciences Inc (GM) has 22,923,301 shares in issue

What is the market cap of Nirvana Life Sciences Inc (GM)?

The market capitalisation of Nirvana Life Sciences Inc (GM) is USD 1.75M

What is the 1 year trading range for Nirvana Life Sciences Inc (GM) share price?

Nirvana Life Sciences Inc (GM) has traded in the range of US$ 0.0763 to US$ 0.08 during the past year

What is the PE ratio of Nirvana Life Sciences Inc (GM)?

The price to earnings ratio of Nirvana Life Sciences Inc (GM) is -0.64

What is the registered address of Nirvana Life Sciences Inc (GM)?

The registered address for Nirvana Life Sciences Inc (GM) is 650 West Georgia Street, Vancouver, British Columbia, V6B 4N8

What is the Nirvana Life Sciences Inc (GM) website address?

The website address for Nirvana Life Sciences Inc (GM) is nirvanalifescience.com

fuagf

+10 wha.. when!? Sabotage-self 101: Put plenty of thought into differentiating your team from others at the top and decide to gamble with Henley. Saving both of McIlroy and Scheffler a lesser part of the strategy. LOL Could be a Henley tip for the next.

NovaWahoo

NovaWahoo 8分前

R BLAGGY IS A CON-MAN

WHERE’S THE BEEF?

SCAM 🚨 SCAM 🚨 SCAM 🚨

HOW MANY BILLIONS IN FLOAT?

BACK TO .0001 TOMORROW

jog49

Trump to issue Fannie Mae and Freddie Mac Emancipation Proclamation on July 4, 2026 at the steps of the U.S. Capitol!

I believe I had a drink too many!

learningcurve2020

learningcurve2020 15分前

Thanks. You’re right, I should.

Chuck McQuade

Chuck McQuade 18分前

I see that as well when I strip away any pre-framed narratives or cheerleading and look at this strictly from a clinical, hard-nosed tax accounting perspective.

I am not here to stir anything up but I like seeing some of the what ifs till we see an 8K next week hopefully.

Otay Buck

Otay Buck 20分前

Not sure. I suspect massive dilution and not a good outcome.

my3sons87

my3sons87 21分前

Yes. Under the UPC system, a successful patent owner can potentially recover compensation for past infringement in addition to obtaining an injunction, but the UPC does not automatically convert an injunction case into a compulsory future royalty license.
The UPC has authority to award:

meirluc

meirluc 21分前

Mani, perhaps Dr. Bosch's talk will establish enough credibility with the UK neuro-oncological community to stimulate UK hospitals to prepare their infrastructure to accommodate the DCVax-L treatment even before the approval and is it feasible to
use the IFR path to start treating patients

Trum

SCAM Alert.... this Pump and Dump is slowly dying. they are getting more and more desperate with their hyping silly and purely false and easily exposed data. Wow just how badly are a few bagholders ( ahem.. insiders....) in for? too sad to see them so so desperate now. this could of been a

JohnnyRotton

JohnnyRotton 24分前

Two key words, "rapidly expanding", we shall see but most of these you only get quarterly numbers so it takes a while.

Hawk05

Hawk05 31分前

Sweden
https://www.instagram.com/reel/DZuiF2bg-wb/?igsh=bmp4ZWpucXNnbnU0

jour_trader

jour_trader 36分前

Nice, thx for sharing. Pharmaceuticals preparations?

UPMI

The weekends and holidays during week days have been my worst day for decades because of the markets closing ,my favorite day has been Monday ; fresh opurtunities .

Talisman33

Talisman33 42分前

Is this the reason Betterhealth.com is heavily discounting? AI has a theory:

The U.S. grocery market is notoriously crowded. Independent health food stores have highly limited shelf space. If a brand does not provide marketing support, in-store demos, or digital ads, the product will

cadillacdave

cadillacdave 43分前

This will be moving up.

CaptBeer

CaptBeer 44分前

CKM Syndrome (Cardiovascular-Kidney-Metabolic Syndrome) is a new disease construct that reflects the substantial interconnections among metabolic risk factors, CKD, and CVD, and their synergistic impacts on morbidity and mortality, as outlined in the CKM Health Presidential Advisory. The ACC/AHA has

ihorchu

ihorchu 45分前

Not at all. That's what cleaning services are for! 😊

lakers17

lakers17 46分前

Nice BTC holding and now over $64,000. I don't expect a big move unless Clarity passes, this war finally ends, the Federal Reserve finally adds 5% crypto (which would be huge) and down the road interest rates drop but an interest rate drop not even happen in 2026.

Lord Andreti

Lord Andreti 46分前

So if you feed AI correctly, it shows you how super complex and difficult it could be for the new company to utilize that NOL :

Effectively continuing the prior business of VGLS is crucial for Canvas 2709, LLC to utilize the $115 million Net Operating Loss (NOL). Here’s a deeper dive

William777

William777 46分前

Another beauty. I will need a extra large bottle of Windex.

GetSeriousOK

GetSeriousOK 47分前

If it's true that Mayer is gone....

Don't any of you even PRETEND that Electrome is going to succeed.

All that pumping about Mayer being a wunderkind, and now you pumpers are going to bash him, aren't you.

Oh. My. God.

Don't worry, it won

Wolf-man jack

Wolf-man jack 49分前

WQLF SAYS: More dis- information from TALISMAN 33 and a Half 🧌. The EPS has stayed steady and a recent Quarter of Increasing due to the two Acquisitions. The EPS steadiness and increase is due to the Acquisitions. They would be higher if revenue from CV SCIENCES had not decreased. The Gross

learningcurve2020

learningcurve2020 51分前

>>Farzin Farzaneh, Professor of Molecular Medicine and head of cGMP cell product manufacturing at King's College London, said: "At King's, we are excited to be undertaking the manufacturing for the DCVax® immune therapies in the UK. Such immune therapies represent an exciting new class of produ

Nirvana Life Sciences (GM)

Northrop Grumman

Altus Copper (EM)

State Street SPDR S&P US...

Brightstar Lottery

Xtrackers India Governme...

Bmo Usd Balanced Etf Por...

Ubs Ag London Branch Aut...

WonderFi Technologies

Ellington Financial

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。